145 related articles for article (PubMed ID: 8637494)
1. Does screening with prostate/specific antigen improve outcomes?
Ohrt D
Minn Med; 1996 Apr; 79(4):50-1. PubMed ID: 8637494
[No Abstract] [Full Text] [Related]
2. How valuable is prostate-specific antigen screening?
Handler S
Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
[No Abstract] [Full Text] [Related]
3. Prostate cancer screening: issues and controversies.
O'Shaughnessy M; Konety B; Warlick C
Minn Med; 2010 Aug; 93(8):39-44. PubMed ID: 20862878
[TBL] [Abstract][Full Text] [Related]
4. PSA screening: the bottom line.
Elhilali MM
CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
[No Abstract] [Full Text] [Related]
5. [Mass screening for prostate cancer in Nagano].
Ishizuka O; Satoh T; Kobayashi S; Nishizawa O
Hinyokika Kiyo; 2001 Nov; 47(11):769-72. PubMed ID: 11771167
[TBL] [Abstract][Full Text] [Related]
6. Best screening tests for prostate cancer.
Moul JW
West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692
[No Abstract] [Full Text] [Related]
7. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
8. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
9. Why PSA testing does have value.
Kirby M
Practitioner; 1997 Jul; 241(1576):363. PubMed ID: 9425708
[No Abstract] [Full Text] [Related]
10. Early detection of prostate cancer. Decreasing the mortality rate.
Oesterling JE
Minn Med; 1996 Apr; 79(4):46-9. PubMed ID: 8637492
[TBL] [Abstract][Full Text] [Related]
11. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
12. Impact of prostate-specific antigen screening on the natural history of prostate cancer.
Rosen MA
Urology; 1995 Dec; 46(6):757-68. PubMed ID: 7502411
[No Abstract] [Full Text] [Related]
13. Screening by the prostate-specific antigen test: what do the patients know?
Diefenbach PN; Ganz PA; Pawlow AJ; Guthrie D
J Cancer Educ; 1996; 11(1):39-44. PubMed ID: 8777154
[TBL] [Abstract][Full Text] [Related]
14. [The use of prostate specific antigen in prostate cancer--prediction for treatment failure].
Egawa S
Nihon Rinsho; 2002 Dec; 60 Suppl 11():100-6. PubMed ID: 12599553
[No Abstract] [Full Text] [Related]
15. [The PSA test does not hold for screening. Good--but not good enough].
Holmström B; Johansson M; Bratt O; Stattin P
Lakartidningen; 2010 Feb 17-23; 107(7):436, 438-9. PubMed ID: 20384076
[No Abstract] [Full Text] [Related]
16. [Serum prostate specific antigen for the early detection of prostate cancer in outpatients of internal medicine].
Otani T; Hayashi Y; Ikuno Y; Hirao Y; Ozono S; Okajima E
Hinyokika Kiyo; 1996 Sep; 42(9):645-9. PubMed ID: 8918662
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer: 4. Screening.
Meyer F; Fradet Y
CMAJ; 1998 Oct; 159(8):968-72. PubMed ID: 9834724
[No Abstract] [Full Text] [Related]
18. [Mass screening for prostate cancer will have to wait. The scientific basis insufficient, more efficient markers necessary].
Damber JE
Lakartidningen; 2003 Sep; 100(38):2916-8, 2921. PubMed ID: 14558209
[No Abstract] [Full Text] [Related]
19. Lead time of prostate cancer detected in population based screening for prostate cancer in Japan.
Ito K; Yamamoto T; Miyakubo M; Takechi H; Ohi M; Shibata Y; Suzuki K
J Urol; 2007 Oct; 178(4 Pt 1):1258-63; discussion 1263-4. PubMed ID: 17698107
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer: enthusiasm for screening.
Kaye KW
Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
